Excitotoxic cell death due to glutamate release is important in the secondary injury following CNS trauma or ischemia. Proinflammatory cytokines also play a role. Both glutamate and tumor necrosis factor-␣ (TNF ␣ ) are released immediately after spinal cord injury. Neurophysiological studies show that TNF ␣ can potentiate the effects of glutamatergic afferent input to produce hyperactivation of brain-stem sensory neurons. Therefore, we hypothesized that TNF ␣ might act cooperatively with glutamate to affect cell death in the spinal cord as well. Nanoinjections of either TNF ␣ (60 pg) or kainate (KA; 32 ng) alone into the thoracic gray resulted in almost no tissue damage or cell death 90 min after injection. However, the combination of TNF ␣ plus KA at these same doses produced a large area of tissue necrosis and neuronal cell death, an effect which was blocked by the AMPA receptor antagonist CNQX (17 ng). These results suggest that secondary injury may involve potentiation of AMPA receptor-mediated excitatory cell death by TNF ␣ .
INTRODUCTION
Spinal cord trauma is characterized by secondary injury processes that exacerbate the initial damage, leading to the progressive expansion of the lesion (reviewed in Beattie & Bresnahan, 2000) . The mechanisms contributing to secondary injury are the subject of intense study since they represent multiple therapeutic targets. It is thought that excitotoxic cell death, mediated by excessive glutamate release, contributes to secondary injury (Panter et al., 1990; Liu et al., 1999; Choi, 1994) . Agents that block glutamate receptors can reduce lesion progression (Wrathall et al., 1994 (Wrathall et al., , 1996 (Wrathall et al., , 1997 Liu et al., 1997; Rosenberg et al., 1999) . Recently, attention has focused on the role of proinflammatory cytokines in secondary injury (Raivich et al., 1999; Rothwell, 1999; Lee et al., 2000) . Microglia, activated soon after injury, elaborate cytokines such as tumor necrosis factor-␣ (TNF ␣ ; Nadeau & Rivest, 2000; Nakamura et al., 1999). TNF ␣ may also enter the lesion area from the periphery, either through compromised blood-brain barrier or via facilitated transport (Pan et al., 1999) , rapidly elevating TNF ␣ tissue levels (Yakovlev & Faden, 1994; Wang et al., 1996; Xu et al., 1998; Bethea et al., 1999) . The role of TNF ␣ in secondary spinal cord injury (SCI) is supported by the observation that IL-10, which blocks the injury-induced increase in TNF ␣ , can protect the spinal cord from secondary injury (Bethea et al., 1999) .
It has been suggested that the presence of multiple, parallel mechanisms of secondary injury will require a combinatorial approach to therapeutics. It might be necessary to block both excitatory amino acid and cytokine pathways in order to affect protection. Here we suggest that some of the deleterious effects of
